IDH mutation is more commonly seen in lower grade gliomas (81%), including astrocytoma (69%), oligoastrocytoma (87%) and oligodendroglioma (89%); whereas the frequency of IDH mutation is substantially lower in primary glioblastoma (~8%)1,9. The gene discussed is IDH2; the disease is central nervous system cancer.